Medication

Although pegged as a weight-loss stock, this drug maker’s core business has long been diabetes. Novo Nordisk (NVO…

February 26, 2026 — 12:01am Save You have reached your maximum number of saved items. Remove items from…

C+D has been informing, supporting and championing community pharmacy since 1859 and is proud to be at the…

What is the name of your business? Move Free Chiropractic What do you do? We offer chiropractic services,…

Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…

An NHS regulator highlighted the ‘rapid take-up’ of new migraine pills to stop a key protein which causes…

FDA PDUFA Goal Date Set for October 17, 2026 PITTSBURGH, Feb. 25, 2026 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS),…

Listen to this article Estimated 4 minutes The audio version of this article is generated by AI-based technology.…

Said to be prescribed to over 120 million people around the globe, metformin is also commonly dropped by…

Many people assume that medicines sold over the counter are inherently safe. After all, if you can buy…

GLP-1s have become a ubiquitous tool for weight loss, but they don’t exactly come with a training manual.…

The data is revealed in a study that estimates 1,577 preventable annual deaths with greater equity in access…

1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market Crash